RNA Formulation Solutions

  1. mRNA/LNP Development And Manufacturing Services

    Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.

  2. CD34+ HSC LNP Kits 4/24/2025

    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  3. Complete Solutions For Every Step Of Pharmaceutical Development 1/12/2023

    By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

  4. Pre-GMP mRNA And LNP Development 11/26/2024

    Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.

  5. New Solutions For Large Molecule Analysis 6/16/2023

    Explore Biozen LC Portfolio

    With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:

    • Charge Variant Analysis
    • Aggregate Analysis
    • Peptide Mapping
    • Intact Mass Intact and Fragment Analysis
    • Glycan Analysis
    • Peptide Quantitation
    • Drug Antibody Ratio (DAR)
    • Oligonucleotide Characterization
  6. Jet-Based Nanoparticle Formulation At Research Scale 8/14/2025

    Developing nanoparticle formulations requires a scalable solution that replicates manufacturing conditions at a small scale. Turbulent jet mixing enables linear scalability while conserving materials.

  7. Metabolite And Lipid Analysis Service 10/29/2024

    Unlock actionable insights into your cell culture process with metabolite and lipid analysis, enabling data-driven optimizations for growth, titer, and product quality.

  8. Delivering Best-In-Class Nanoparticles 6/30/2025

    Achieve uniformity and control in nanoparticle synthesis with an advanced system that streamlines production, reduces human intervention, and delivers exceptional particle characteristics for diverse applications.

  9. Labscale Lipid Nanoparticle Production: IJM NanoScaler 12/9/2024

    The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.

  10. Cleanrooms And Equipment For mRNA Drug Manufacturing 6/9/2023

    Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success

    Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.